SCHEMBL30169056

SCHEMBL30169056

CC(C)(C)OC(=O)N[C@@H](CCC(N)=O)COc1ccc(F)c(C#CCCCC(=O)O)c1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ AAK1 Q2M2I8 5/20 0.38
▸ PTPN1 P18031 1/20 0.34
▸ ITGB1 P05556 1/20 0.34
▸ ITGA4 P13612 1/20 0.34
▸ S1PR3 Q99500 1/20 0.33
▸ FFAR1 O14842 1/20 0.32
▸ FFAR4 Q5NUL3 1/20 0.32
▸ TRPA1 O75762 1/20 0.32
▸ SCN9A Q15858 1/20 0.32
▸ REN P00797 1/20 0.31
▸ CTSS P25774 1/20 0.31
▸ CTSK P43235 1/20 0.31
▸ ITGB3 P05106 1/20 0.31
▸ ITGA2B P08514 1/20 0.31
▸ HDAC3 O15379 3/20 0.31
▸ HDAC4 P56524 3/20 0.31
▸ HDAC1 Q13547 3/20 0.31
▸ HDAC7 Q8WUI4 3/20 0.31
▸ HDAC2 Q92769 3/20 0.31
▸ HDAC10 Q969S8 3/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22525489 1.00 AAK1 (0.38) AAK1PTPN1ITGB1ITGA4S1PR3
SCHEMBL22525462 0.92 AAK1 (0.39) AAK1ITGB1ITGA4RENCTSS
SCHEMBL30169032 0.92 AAK1 (0.39) AAK1ITGB1ITGA4RENCTSS
SCHEMBL22526704 0.87 ITGB1 (0.42) AAK1ITGB1ITGA4FFAR1FFAR4
SCHEMBL26238286 0.86 AAK1 (0.42) AAK1ITGB1ITGA4HDAC3HDAC4
SCHEMBL26238218 0.85 AAK1 (0.38) AAK1PTPN1ITGB1ITGA4SCN9A
SCHEMBL22526703 0.85 ITGB1 (0.38) AAK1ITGB1ITGA4FFAR1HDAC3
SCHEMBL26238326 0.84 ITGB1 (0.36) AAK1ITGB1ITGA4SCN9ACTSS
SCHEMBL30341933 0.83 AAK1 (0.47) AAK1ITGB1ITGA4HDAC3HDAC4
SCHEMBL22526099 0.83 AAK1 (0.37) AAK1ITGB1ITGA4RENHDAC3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250059221-A1 STAT DEGRADERS AND USES THEREOF KYMERA THERAPEUTICS, INC. 2025-02-20 — — US disclosed
US-12077555-B2 STAT degraders and uses thereof KYMERA THERAPEUTICS, INC. (US) 2024-09-03 — — US disclosed
US-11746120-B2 Stat degraders and uses thereof KYMERA THERAPEUTICS, INC. (US) 2023-09-05 — — US disclosed
US-20230120381-A1 STAT DEGRADERS AND USES THEREOF KYMERA THERAPEUTICS, INC. 2023-04-20 — — US disclosed
US-20230084113-A1 STAT DEGRADERS AND USES THEREOF KYMERA THERAPEUTICS, INC. 2023-03-16 — — US disclosed
US-11485750-B1 STAT degraders and uses thereof KYMERA THERAPEUTICS, INC. (US) 2022-11-01 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230084113-A1 STAT DEGRADERS AND USES THEREOF STAT4, STAT1, STAT3 AAK1 2860/4885PTPN1 25/4885ITGB1 4445/4885
US-20230120381-A1 STAT DEGRADERS AND USES THEREOF STAT4, STAT1, STAT3 AAK1 2860/4885PTPN1 25/4885ITGB1 4445/4885
US-12077555-B2 STAT degraders and uses thereof STAT4, STAT1, STAT3 AAK1 2860/4885PTPN1 25/4885ITGB1 4445/4885
US-20250059221-A1 STAT DEGRADERS AND USES THEREOF STAT4, STAT1, STAT3 AAK1 2860/4885PTPN1 25/4885ITGB1 4445/4885
US-11746120-B2 Stat degraders and uses thereof STAT4, STAT1, STAT3 AAK1 2860/4885PTPN1 25/4885ITGB1 4445/4885
US-11485750-B1 STAT degraders and uses thereof STAT4, STAT1, STAT3 AAK1 2860/4885PTPN1 25/4885ITGB1 4445/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback